FDA Updates

Approved and upcoming drugs to look forward to this year.

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 

Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.

What you need to know about the FDA’s most recent novel drug approvals.

FDA approves lofexidine for opioid withdrawal symptoms.

The FDA recently approved cannabidiol oral solution to treat seizures.

The latest New Drug Review covers Amgen’s migraine medication.

The drug is the first approved under the agency's new, quicker generic approval designation.

Our latest New Drug Review covers Dova’s most recent medication.

A roundup of the 10 most recent FDA-approved medications.

Betrixaban has been approved by the FDA for patients at risk for thromboembolisms. 

What you need to know about the latest FDA approval.

What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.

FDA approves apalutamide for castration-resistant prostate cancer.

Netarsudil opthalmis solution (Rhopressa, Aerie Pharmaceuticals), is approved by the FDA for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.

Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.

Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.

Abilify MyCite is the first drug to contain a bit of technology that reports that it has been taken as prescribed.